Literature DB >> 15737316

[Pseudomyxoma peritonei: new concept and new therapeutic approach].

R Loungnarath1, S Causeret, C Brigand, F N Gilly, O Glehen.   

Abstract

Pseudomyxoma peritonei is a rare disease, usually diagnosed after the discover of "jelly belly" by laparotomy. With the progress of immunohistochemistry, most authors now acknowledge the appendix to be the principal origin of this disease. Pseudomyxoma peritonei need to considered as border line malignant disease because of its inevitable persistence and progression without adapted therapeutic approach: cytoreductive surgery combined with perioperative intraperitoneal chemotherapy (intraperitoneal chemohyperthermia and/or immediate postoperative intraperitoneal chemotherapy) into specialized centres. The principal prognostic factors are the prior surgical history, the completeness of cytoreduction and especially the histopathologic grade.

Entities:  

Mesh:

Year:  2004        PMID: 15737316     DOI: 10.1016/j.anchir.2004.09.016

Source DB:  PubMed          Journal:  Ann Chir        ISSN: 0003-3944


  6 in total

1.  Appendiceal mucocoeles and pseudomyxoma peritonei.

Authors:  Anupam Dixit; John H P Robertson; Satvinder S Mudan; Charles Akle
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

Review 2.  Management of pseudomyxoma peritonei.

Authors:  Zhi-Bo Qu; Lian-Xin Liu
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

3.  Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis.

Authors:  Cristina Semino-Mora; Hui Liu; Thomas McAvoy; Carol Nieroda; Kimberley Studeman; Armando Sardi; Andre Dubois
Journal:  Ann Surg Oncol       Date:  2008-02-26       Impact factor: 5.344

4.  [Pseudomyxoma peritonei (PMP) secondary to mucinous carcinoma of the ovary: a case study].

Authors:  Mohamed Said Belhamidi; Youssef Zorkani; Hicham Krimou; Abdessamad Kaoukabi; Mohamed Menfaa; Fouad Sakit; Karim Choho
Journal:  Pan Afr Med J       Date:  2019-08-02

5.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: results from a 7-year experience.

Authors:  Giulia Montori; Federico Coccolini; Paola Fugazzola; Marco Ceresoli; Matteo Tomasoni; Carolina Rubicondo; Stefano Raimondo; Domenico Pinelli; Michele Colledan; Luigi Frigerio; Luca Ansaloni
Journal:  J Gastrointest Oncol       Date:  2018-04

6.  A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei.

Authors:  Jeremy J Gilbreath; Cristina Semino-Mora; Christopher J Friedline; Hui Liu; Kip L Bodi; Thomas J McAvoy; Jennifer Francis; Carol Nieroda; Armando Sardi; Andre Dubois; David W Lazinski; Andrew Camilli; Traci L Testerman; D Scott Merrell
Journal:  Orphanet J Rare Dis       Date:  2013-07-12       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.